Carpmaels & Ransford has retained its “highly recommended” status in the IAM Patent 1000 rankings for 2017, with a number of partners receiving individual recognition.
According to the publication: “Carpmaels & Ransford continues to justify its standing as one of the jurisdiction’s premier operators. Its traditional strength in providing high-quality prosecution services is complemented by a flourishing litigation practice. Blending technical know-how with courtroom dexterity, it can perform near miracles at opposition and approaches disputes with unerring confidence. “Both the attorney and litigation teams are exceptionally professional and knowledgeable. Their ability to easily interact and provide a comprehensive overview of entire projects is invaluable.” Fronting the outfit’s formidable chemistry group, Susan Kirsch is held in the highest esteem by peers and masterfully navigates oppositions before the EPO. She is a font of knowledge on SPC strategy – an area in which Edward Oates also excels. “An extremely capable professional”, Oates successfully defended Teva Women’s Health’s Seasonique contraceptive before the EPO in 2016, as well as devising a shrewd SPC filing strategy for the company. A staunch ally of global heavyweights Eli Lilly and Novartis, the “wonderful” Cameron Marshall effortlessly dispatches even the most complex biotechnology and pharmaceutical oppositions. Marshall and James Warner recently delivered a successful defence of Novartis’s Aclasta product against five opponents at the EPO, despite the UK portion of the patent being previously revoked in the UK High Court and UK Court of Appeal. Hugh Goodfellow is a top-tier adviser for a wealth of major rights holders; the life sciences chief’s expansive practice seamlessly links the firm’s prosecution division with its dispute resolution arm. Engineering and IT briefs are handled expertly by managing partner Richard Jackson; an “impressive, charming, relaxed guy who is incredibly sharp underneath, he is the guiding hand behind much of the firm’s success”. John Brunner also blazes a trail in the IT sphere and boasts a gilded track record in securing valuable patents for high-tech clients. A multi-jurisdictional litigation ace, Ian Kirby captains the firm’s dispute resolution team, which has been bolstered by the recent arrival of David Wilson; with 20 years’ experience to draw upon, Wilson truly knows the lie of the land in pharmaceutical and telecommunications conflicts. With a sound commercial focus built upon rich in-house experience, Camilla Balleny took the lead on a complex dispute relating to Cubist’s Cubicin antibiotic – a case which highlighted the fluidity with which the firm’s attorneys and solicitors combine forces under one roof.”
Carpmaels & Ransford continues to justify its standing as one of the jurisdiction’s premier operators. Its traditional strength in providing high-quality prosecution services is complemented by a flourishing litigation practice.